Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

MPEG-G: leveraging the use of genomic information

The development and rapid progress of high-throughput sequencing (HTS) technologies has the potential of enabling the use of genomic information as an everyday practice in several fields. With the release of the latest HTS machines the cost of a whole genome sequencing for a human genome has dropped to merely US $1,000. It is expected that within the next few years such cost could drop to about US $100. Such achievements in the reduction of sequencing costs opened the doors to personalized medicine, where the genomic information of patients can be sequenced and analyzed as frequently as done today for standard blood tests. However, the ever-growing volume of sequencing data is already a serious obstacle to the wider diffusion of sequencing in public health. The associated IT costs, related to storing, transmitting and processing the large volumes of data, will soon largely exceed the costs of sequencing. The lack of appropriate representations and efficient compression technologies is widely recognized as a critical element limiting the potential of genomic data usage for scientific and public health purposes [1].

The MPEG-G standard is currently the largest coordinated and international effort addressing the problems and limitations of current technologies and products towards a truly efficient and economical handling of genomic information. MPEG-G utilizes the latest technology to compress and transport sequencing data for complex use cases that are currently not supported by existing formats. Notable use cases addressed by MPEG-G include:

  • Selective access to compressed data
  • Data streaming
  • Compressed file concatenation
  • Genomic studies aggregation
  • Enforcement of privacy rules
  • Selective encryption of sequencing data and metadata
  • Annotation and linkage of genomic segments
  • Interoperability with main existing technologies and legacy formats
  • Incremental update of sequencing data and metadata

This white paper summarizes the objectives and the benefits of the upcoming MPEG-G standard by providing:

  • a brief description of the requirements and the methodology used to develop the various parts of the MPEG-G standard,
  • an exemplary overview of the current MPEG-G compression performance,
  • an introduction to the main technical features of MPEG-G,
  • a summary of possible applications and usage scenarios of the MPEG-G standard.

 

Read the full White Paper here: Objectives and Benefits of MPEG-G

Schedule a call

[contact-form-7 id="224" title="contact call"]